Medicine
Sodium bicarbonate 4200 mg/50 mL injection
Sodium bicarbonate 4200 mg/50 mL injection is a generic prescription medicine for intravenous use, made by 19 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Protect from freezing. Store at 20°C to 25°C (68°F to 77°F).
Key facts
- Active ingredient (INN)
- Sodium bicarbonate
- Brand
- Sold under the generic name
- Strength
- 4200 mg/50 mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 20 vials of 50 mL, 25 vials of 50 mL, 10 cartons of 50 mL and 33 more
- Manufacturers
- Anthea PharmaIndiaGlenmark PharmaceuticalsIndiaSteriscience SpecialtiesIndiaSun Pharmaceutical IndustriesIndiaMedical Purchasing SolutionsExela Pharma SciencesHospiraA-S Medication SolutionsBryant Ranch PrepackCivica
- Origin register
- US FDA, United States
- Storage
- Protect from freezing. Store at 20°C to 25°C (68°F to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- B05CB04 Sodium bicarbonate
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 June 2000
- Identifiers
- RxCUI 1868486, 792582, 1868469 +4DailyMed set ID bfc9c321-665c-ca97-e053-2995a90a7954, ba92f45a-0187-4709-aa70-462b8dae09e9, aea54f8d-1cdd-4a5c-a2f7-7317ae4c8fbc +28NDC 71872-7247, 80830-2305, 81665-200 +27Application ANDA202432, ANDA217523, ANDA216364 +8
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 20 vial in 1 carton / 50 mL in 1 vial | 83854-001-20 | Anthea PharmaIndia | 26 June 2025 |
| 25 vial in 1 carton / 50 mL in 1 vial | 83854-001-25 | Anthea PharmaIndia | 26 June 2025 |
| 25 vial in 1 carton / 50 mL in 1 vial | 68462-951-65 | Glenmark PharmaceuticalsIndia | 7 August 2025 |
| 20 vial in 1 carton / 50 mL in 1 vial | 82449-000-05 | Steriscience SpecialtiesIndia | 8 March 2024 |
| 25 vial in 1 carton / 50 mL in 1 vial | 70095-050-03 | Sun Pharmaceutical IndustriesIndia | 15 March 2024 |
| 25 vial in 1 carton / 50 mL in 1 vial | 51754-5001-4 | Exela Pharma Sciences | 1 August 2022 |
| 20 vial in 1 carton / 50 mL in 1 vial | 51754-5001-5 | Exela Pharma Sciences | 1 August 2019 |
| 25 vial in 1 carton / 50 mL in 1 vial | 51754-8020-4 | Exela Pharma Sciences | 25 August 2026 |
| 25 vial in 1 carton / 50 mL in 1 vial | 51754-8888-4 | Exela Pharma Sciences | 9 June 2026 |
| 25 vial, single-dose in 1 tray / 50 mL in 1 vial, single-dose | 0409-6625-14 | Hospira | 1 March 2021 |
| 25 vial, single-dose in 1 tray / 50 mL in 1 vial, single-dose | 0409-6625-35 | Hospira | 15 October 2020 |
| 10 carton in 1 package / 1 syringe in 1 carton / 50 mL in 1 syringe | 0409-6637-14 | Hospira | 23 July 2020 |
| 25 vial, single-dose in 1 carton / 50 mL in 1 vial, single-dose | 80830-2305-2 | Amneal Pharmaceuticals | 13 January 2026 |
| 25 vial, single-dose in 1 tray / 50 mL in 1 vial, single-dose | 63323-089-50 | Fresenius Kabi | 25 August 2025 |
| 1 syringe in 1 carton / 50 mL in 1 syringe | 76329-3352-1 | International Medication Systems | 1 June 2000 |
| 20 vial in 1 carton / 50 mL in 1 vial | 81298-7620-3 | Long Grove Pharmaceuticals | 30 September 2024 |
| 10 vial, single-dose in 1 carton / 50 mL in 1 vial, single-dose | 71357-004-10 | Milla Pharmaceuticals | 7 August 2026 |
| 20 vial in 1 carton / 50 mL in 1 vial | 81665-200-05 | Omnivium Pharmaceuticals | 16 June 2023 |
| 25 vial in 1 carton / 50 mL in 1 vial | 81665-200-25 | Omnivium Pharmaceuticals | 16 June 2023 |
| 1 carton in 1 bag / 1 syringe in 1 carton / 50 mL in 1 syringe | 71872-7097-1 | Medical Purchasing Solutions | 18 October 2019 |
| 1 vial, single-dose in 1 bag / 50 mL in 1 vial, single-dose | 71872-7247-1 | Medical Purchasing Solutions | 30 March 2021 |
| 1 carton in 1 bag / 1 syringe in 1 carton / 50 mL in 1 syringe | 71872-7266-1 | Medical Purchasing Solutions | 24 August 2021 |
| 1 vial in 1 bag / 50 mL in 1 vial | 71872-7310-1 | Medical Purchasing Solutions | 20 September 2023 |
| 1 vial in 1 bag / 50 mL in 1 vial | 71872-7371-1 | Medical Purchasing Solutions | 15 April 2026 |
| 1 vial in 1 bag / 50 mL in 1 vial | 71872-7376-1 | Medical Purchasing Solutions | 9 June 2026 |
| 50 mL in 1 vial | 50090-0530-0 | A-S Medication Solutions | 1 March 2021 |
| 1 vial in 1 carton / 50 mL in 1 vial | 50090-6813-0 | A-S Medication Solutions | 8 November 2023 |
| 20 carton in 1 box / 1 vial, single-dose in 1 carton / 50 mL in 1 vial, single-dose | 72572-200-20 | Civica | 10 June 2026 |
| 25 vial in 1 carton / 50 mL in 1 vial | 72572-740-25 | Civica | 1 February 2024 |
| 50 mL in 1 vial | 84549-050-03 | ProPharma Distribution | 27 August 2025 |
| 50 mL in 1 syringe | 84549-352-01 | ProPharma Distribution | 1 September 2025 |
| 20 vial in 1 carton / 50 mL in 1 vial | 72162-2314-2 | Bryant Ranch Prepack | 22 May 2024 |
| 25 vial in 1 carton / 50 mL in 1 vial | 72162-2314-4 | Bryant Ranch Prepack | 22 May 2024 |
| 1 syringe in 1 carton / 50 mL in 1 syringe | 51662-1383-1 | HealthFirst | 18 May 2020 |
| 10 pouch in 1 case / 1 syringe in 1 pouch / 50 mL in 1 syringe | 51662-1383-3 | HealthFirst | 12 June 2022 |
| 1 syringe in 1 carton / 50 mL in 1 syringe | 70518-4158-0 | Remedyrepack | 14 August 2024 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 3 June 1986 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Sodium bicarbonate
Clinical summary
Sodium bicarbonate is an osmotic laxative indicated to raise plasma pH in adults and pediatric patients with clinically significant metabolic acidosis, among other approved uses. It is available as injection for intravenous use. MedsAcross supplies Sodium bicarbonate for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Sodium bicarbonateFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Sodium Bicarbonate prescribing information (Amneal Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Sodium bicarbonate 4200 mg/50 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.